Andrew D. Dickinson
Chief Financial Officer at Gilead Sciences. Based in Foster City, California.
- Rank
- 4201st of 14,644
- Companies held
- 1
- Largest holding
- GILD, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
What the $26.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Gilead Sciences GILD Common Stock | Directly | 158,096 | $166.53 | $26.3M | 100.0% | Form 4, Nov 16, 2026 |
Share counts are the amounts Andrew D. Dickinson reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | GILD | 3,000 | $171.47 | $514K | View |
| Oct 15, 2026 | Sold | GILD | 3,000 | $156.22 | $469K | View |
| Sep 15, 2026 | Sold | GILD | 3,000 | $145.29 | $436K | View |
| Aug 17, 2026 | Sold | GILD | 3,000 | $138.36 | $415K | View |
| Jul 15, 2026 | Sold | GILD | 3,000 | $129.93 | $390K | View |
| Jun 15, 2026 | Sold | GILD | 3,000 | $125.40 | $376K | View |
| May 15, 2026 | Sold | GILD | 3,000 | $132.27 | $397K | View |
| Apr 15, 2026 | Sold | GILD | 3,000 | $140.96 | $423K | View |
| Mar 16, 2026 | Sold | GILD | 3,000 | $144.23 | $433K | View |
| Feb 17, 2026 | Sold | GILD | 3,000 | $154.43 | $463K | View |
| Jan 15, 2026 | Sold | GILD | 3,000 | $124.31 | $373K | View |
| Dec 15, 2025 | Sold | GILD | 3,000 | $122.00 | $366K | View |
| Nov 17, 2025 | Sold | GILD | 2,500 | $125.23 | $313K | View |
| Oct 15, 2025 | Sold | GILD | 2,500 | $118.08 | $295K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4198 | Luc Seraphin President and CEO, Rambus. San Jose, CA | $26.3M |
| 4199 | William E. Jordan CHIEF LEGAL & POLICY OFFICER, EQT. Pittsburgh, PA | $26.3M |
| 4200 | Kevin McCulloch See Remarks, Xeris Biopharma Holdings. Chicago, IL | $26.3M |
| 4201 | Andrew D. Dickinson Chief Financial Officer, Gilead Sciences. Foster City, CA | $26.3M |
| 4202 | Randy L. Newman Director, Alerus Financial. Grand Forks, ND | $26.3M |
| 4203 | Chad R. Abraham CEO and Chairman, Piper Sandler Companies. Charlotte, NC | $26.3M |
| 4204 | Jennifer Tejada Executive Chair, PagerDuty. San Francisco, CA | $26.3M |
Other Gilead Sciences insiders
All GILD insiders- Daniel O'Day$91.9MChairman & CEO. #1602 overall
- Kevin E. Lofton$32.7MDirector. #3382 overall
- Johanna Mercier$18.4MChief Comm & Corp Aff Officer. #5302 overall
- Merdad Parsey$13.8MChief Medical Officer. #6736 overall
- Diane E. Wilfong$7.7MInterim Corp Controller & CAO. #10648 overall
- Deborah H. Telman$7.3MEVP, Corporate Affairs & GC. #9581 overall
Questions
How much stock does Andrew D. Dickinson own?
Andrew D. Dickinson holds $26,327,727 in listed stock based on SEC filings and current prices, mostly Gilead Sciences (GILD). That ranks 4201st on the Stock Rich List.
Is this Andrew D. Dickinson's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Andrew D. Dickinson last buy or sell stock?
The most recent open-market trade on file is a sale of 3,000 GILD shares on Nov 16, 2026 at $171.47.